This report is an insightful source for data, analysis and strategic insights into a Osmetech plc's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook In Vitro Diagnostics
3 Business Description
- 3.1 Business Overview
- 3.2 Major Products and Services
  - 3.2.1 Overview
4 History
5 Key Employees
6 Key Employee Biographies
7 Company Statement
8 Locations And Subsidiaries
- 8.1 Head Office
9 Recent Developments
- 9.1 Financial Announcements
  - 9.1.1 Mar 28, 2008: Osmetech Reports Preliminary 2007 Results
  - 9.1.2 Sep 27, 2007: Osmetech Reports H1 2007 Results
  - 9.1.3 Mar 20, 2007: Osmetech Reports 2006 Results
- 9.2 Corporate Communications
  - 9.2.1 Aug 12, 2008: Osmetech Announces Board Changes
  - 9.2.2 Feb 14, 2007: Osmetech Appoints Executive Director
- 9.3 Product News
  - 9.3.1 Jul 21, 2008: Osmetech Announces Approval Of eSensor XT-8 Molecular Diagnostics Platform
  - 9.3.2 Feb 12, 2008: Marshfield Clinic Discovers Gene Variant Which Will Significantly Enhance the Accuracy of Molecular Tests for Warfarin Metabolism
  - 9.3.3 Feb 12, 2008: Marshfield Clinic Discovers Gene Variant Which Will Significantly Enhance the Accuracy of Molecular Tests for Warfarin Metabolism
  - 9.3.4 Jan 07, 2008: Warfarin Test Submitted for FDA approval
- 9.4 Product Approvals
  - 9.4.1 Jul 21, 2008: Osmetech Announces Approval Of eSensor XT-8 Molecular Diagnostics Platform
  - 9.4.2 Jan 07, 2008: Warfarin Test Submitted for FDA approval
10 Osmetech plc Pipeline Products
- 10.1 Osmetech plc Product Pipeline Analysis
  - 10.1.1 Osmetech plc Pipeline Products By Equipment Type
  - 10.1.2 Osmetech plc Pipeline Products By Development Stage
  - 10.1.3 Osmetech plc Pipeline Products By Therapy Area
  - 10.1.4 Osmetech plc Pipeline Products By Clinical Trials
  - 10.1.5 Osmetech plc Pipeline Products By News Summary
- 10.2 eSensor 2C9/VKOR test
  - 10.2.1 Product Description
  - 10.2.2 Product Status
  - 10.2.3 Clinical Trials
  - 10.2.4 Product Milestone
- 10.3 eSensor XT-8 System
  - 10.3.1 Product Description
  - 10.3.2 Product Status
  - 10.3.3 Product Milestone
- 10.4 CYP450/VKOR
  - 10.4.1 Product Description
  - 10.4.2 Product Status
  - 10.4.3 Product Milestone
11 Appendix
- 11.1 Methodology
  - 11.1.1 Coverage
  - 11.1.2 Secondary Research
  - 11.1.3 Primary Research
  - 11.1.4 Expert Panel Validation
- 11.2 Contact Us
- 11.3 About Global Markets Direct
- 11.4 Disclaimer
1 List of Tables
- Table 1: Osmetech plc,Key Facts
- Table 2: Osmetech plc, Key Employees,
- Table 3: Osmetech plc Pipeline Products by Equipment Type
- Table 4: Osmetech plc Pipeline Products By Development Stage
- Table 5: Osmetech plc Pipeline Products By Therapy Area
- Table 6: Osmetech plc Pipeline Products By Clinical Trials
- Table 7: Osmetech plc Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: Osmetech plc Pipeline Products By Development Stage
- Figure 2: Osmetech plc Pipeline Products By News Summary
- Figure 3: Global Markets Direct Methodology

Pharmaceutical Market Research

Osmetech plc Product Pipeline Analysis